Topic

Novartis

Novartis Q1 profit down on US generic erosion

Published 28 Apr, 2026 10:13am

Quarterly group operating income, adjusted for special items, came in at $4.9 billion

Novartis to exit Indian unit in $159 million deal

Published 20 Feb, 2026 10:01am

The stake will be acquired by a consortium of WaveRise Investments, ChrysCapital and Two Infinity Partners

Drugmakers brace for Europe pricing fight after Trump’s US price-cut deals

Updated 09 Jan, 2026 08:17am

Global drugmakers face a battle in 2026 to secure higher prices for their prescription medicines in Europe after...

Drugmakers raise US prices on 350 medicines despite pressure from Trump

Published 01 Jan, 2026 07:36am

Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and...

ICI Pakistan, now LCI, rejects claims of exiting pharma manufacturing

Published 26 Nov, 2025 10:15am

Pharmaceutical business continues to grow, says the company

EDITORIAL: Exit of MNCs

Updated 25 Nov, 2025 08:06am

EDITORIAL: According to a Business Recorder exclusive, the government is considering the introduction of investment...

Phase-I assessment over: CCP clears IIL’s takeover of Novartis

Published 09 Nov, 2025 03:22am

ISLAMABAD: The Competition Commission of Pakistan (CCP) has authorized the acquisition of Novartis Pharma (Pakistan)...

Novartis Q3 operating income up 6% on new drug sales

Published 28 Oct, 2025 11:29am

FRANKFURT: Swiss drugmaker Novartis, on a deal-making spree this year, reported a gain in operating income of 6% as...

Novartis to acquire Tourmaline Bio for $1.4 billion

Published 09 Sep, 2025 12:53pm

BERLIN: Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company...

Novartis slightly raises 2025 earnings forecast, citing strong Q2

Published 17 Jul, 2025 11:12am

BERLIN: Novartis on Thursday posted a slightly more optimistic full-year earnings forecast, citing the strong growth...

Novartis gets approval for first malaria drug for babies and children

Published 08 Jul, 2025 11:50am

ZURICH: Novartis on Tuesday said it had received approval in Switzerland for Coartem, which it said was the first...

Novartis more upbeat on 2025 guidance after strong Q1 momentum

Published 29 Apr, 2025 11:18am

FRANKFURT: Novartis on Tuesday issued a more optimistic full-year earnings guidance, citing strong growth of drugs...

Novartis agrees to acquire Anthos for up to $3.1 billion

Published 11 Feb, 2025 12:13pm

Swiss pharmaceutical giant Novartis said on Tuesday it has agreed to acquire biopharma firm Anthos Therapeutics for...

Novartis raises annual sales guidance until 2028

Published 21 Nov, 2024 11:21am

FRANKFURT: Novartis on Thursday raised its medium-term sales guidance, predicting 6% annual growth through 2028,...

Novartis lifts 2024 guidance for third time on wider use of its drugs

Published 29 Oct, 2024 12:34pm

FRANKFURT: Swiss drugmaker Novartis raised its 2024 earnings guidance for the third time on Tuesday, driven by wider...

Sanofi MS drug tolebrutinib misses goal in relapsing disease trials

Published 02 Sep, 2024 12:36pm

Sanofi’s most advanced multiple sclerosis (MS) drug candidate has missed the main goal of two late-stage trials to...

Novartis aims for 5% annual sales growth through 2027

Published 28 Nov, 2023 12:50pm

FRANKFURT: Novartis said it was targeting annual sales growth of 5% per year until 2027 and a core operating income...

Novartis to buy Chinook for up to $3.5bn in boost to late-stage pipeline

Published 19 Jun, 2023 06:54am

BERN: Novartis has agreed to acquire Seattle-based biotech firm Chinook Therapeutics for up to $3.5 billion to boost...

Novartis raises year forecast after sales boost

Published 25 Apr, 2023 12:45pm

ZURICH: Pharmaceutical giant Novartis said Tuesday it was increasing its full-year sales and profits outlook after...

Novartis net profit down in Q3 amid restructuring

Published 25 Oct, 2022 01:02pm

ZURICH: Swiss pharmaceutical giant Novartis on Tuesday reported a sharp drop in net profits in the third quarter,...

Novartis to save at least $1bn by 2024 thanks to simplified structure

Published 04 Apr, 2022 12:47pm

ZURICH: Novartis said on Monday it was integrating its pharmaceuticals and oncology units into an innovative...

Novartis suspends some business activities in Russia

Published 22 Mar, 2022 01:29pm

GENEVA: Swiss drugmaker Novartis said on Tuesday it was suspending capital investments, media advertising, and other...

Novartis Q4 core operating income gains 9%

Published 02 Feb, 2022 11:33am

FRANKFURT: Novartis reported fourth-quarter core operating income gained 9% as higher drug sales offset in increase...

Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners

Published 10 Jan, 2022 12:19pm

ZURICH: Novartis said it will license in a new drug it has been developing with Molecular Partners to treat ...

Novartis sees strong interest in Sandoz generics unit

Published 12 Dec, 2021 04:19am

ZURICH: Novartis is seeing strong interest from private equity investors as well as from other pharmaceuticals...

Novartis CEO says Sandoz attracting interest

Published 10 Dec, 2021 11:45am

ZURICH: Novartis's potential sale of its Sandoz generic drug business is attracting interest from possible buyers,...

Roche buys back voting rights from rival Novartis for $20.7bn

Published 04 Nov, 2021 02:13pm

ZURICH: Novartis AG, a shareholder in Roche for more than 20 years, said on Thursday the two Swiss drugmakers had...

Novartis sells its Roche stake to Roche for $20.7bn

Published 04 Nov, 2021 11:47am

ZURICH: Novartis AG, a shareholder in Roche for more than 20 years, said on Thursday the two Swiss drugmakers had...

Novartis extends deal to make Pfizer/BioNTech vaccines

Published 21 Oct, 2021 11:15am

ZURICH: Novartis has agreed to expand its fill-and-finish support for the Pfizer/BioNTech COVID-19 vaccine by using...

Novartis to launch new Zolgensma trial after FDA lifts restriction

Updated 03 Aug, 2021 10:54am

Novartis said it March it was laying off 400 people and closing a US gene therapy location as sales momentum for Zolgensma stalled last year

BR100
BR30
KSE100
KSE30
KMI30

1D 5D 3M 6M 1Y

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / Jul 17	278.16
USD PKR Interbank Buying / Jul 17	277.96
USD to Japanese Yen / Jul 17	162.40
USD to Swiss Franc / Jul 17	0.81
Pound Sterling to USD / Jul 17	1.35
Euro to USD / Jul 17	1.14
SOFR % / Jul 17	3.60

Stock	Volume
S&P 500 / Jul 17	7,457.69
India Sensex / Jul 17	78,151.45
Tokyo Nikkei / Jul 17	64,141.12
Nasdaq / Jul 17	25,520.24
Hang Seng / Jul 17	24,562.24
FTSE 100 / Jul 17	10,600.37
Dow Jones / Jul 17	52,146.42
Germany DAX 30 / Jul 17	24,830.98
France CAC40 / Jul 17	8,338.81

Item	Value
Crude Oil USD/Barrel / Jul 17	82.49
Karachi Cotton PKR/37.32 KG / Jul 17	18,780
Gold 10 Grams PKR / Jul 17	361,656
Gold Spot USD/Ounce / Jul 17	4,017.39
Cotton US¢/pound / Jul 17	78.63
Petrol/Litre / Jul 19	316.15
Diesel/Litre / Jul 19	354.35

Gainers
Losers
Leaders

Stock	Price
Dadabhoy Cement / Jul 17 Dadabhoy Cement Industries Limited(DBCI)	17.01 ▲ 1.55 (10.03%)
Ruby Textile / Jul 17 Ruby Textile Mills Limited(RUBY)	17.59 ▲ 1.6 (10.01%)
Crescent Cotton / Jul 17 Crescent Cotton Mills Limited(CCM)	53.68 ▲ 4.88 (10%)
National Silk / Jul 17 The National Silk & Rayon Mills Limited(NSRM)	272.21 ▲ 24.75 (10%)
Suhail Jute / Jul 17 Suhail Jute Mills Limited(SUHJ)	223.96 ▲ 20.36 (10%)
Baba Farid Sugar / Jul 17 Baba Farid Sugar Mills Limited(BAFS)	418.56 ▲ 38.05 (10%)
Shadman Cotton / Jul 17 Shadman Cotton Mills Limited(SHCM)	50.61 ▲ 4.6 (10%)
Asia Ins. / Jul 17 Asia Insurance Company Limited(ASIC)	34.45 ▲ 3.13 (9.99%)
Olympia Mills / Jul 17 Olympia Mills Limited(OML)	107.58 ▲ 9.65 (9.85%)
TPL Trakker Ltd / Jul 17 TPL Trakker Limited(TPLT)	27.91 ▲ 2.5 (9.84%)

Stock	Price
Tariq Corp. (R) / Jul 17 Tariq Corporation Limited(Right)(TCORPR2)	2.70 ▼ -0.89 (-24.79%)
First Punjab Modaraba / Jul 17 First Punjab Modaraba(FPJM)	11.04 ▼ -1.23 (-10.02%)
Khairpur Sug. / Jul 17 Khairpur Sugar Mills Limited(KPUS)	1,871.47 ▼ -207.94 (-10%)
Service Textile / Jul 17 Service Industries Textiles Limited(SERT)	62.27 ▼ -6.92 (-10%)
S.G.Power / Jul 17 S.G. Power Limited(SGPL)	97.59 ▼ -10.84 (-10%)
Mughal Iron & Steel(C) / Jul 17 Mughal Iron & Steel Industries Ltd (C)(MUGHALC)	63 ▼ -6.99 (-9.99%)
Fateh Sports / Jul 17 Fateh Sports Wear Limited(FSWL)	150.29 ▼ -16.65 (-9.97%)
Paramount Spinning / Jul 17 Paramount Spinning Mills Limited(PASM)	10.91 ▼ -1.1 (-9.16%)
Power Cem(Pref) / Jul 17 Power Cement (Pref)(POWERPS)	23.62 ▼ -2.36 (-9.08%)
Supernet Tech. / Jul 17 Supernet Technologies Limited(STL)	41.34 ▼ -3.72 (-8.26%)

Stock	Volume
Cnergyico PK / Jul 17 Cnergyico PK Limited(CNERGY)	86,491,992 ▲ 0.19
TPL Properties / Jul 17 TPL Properties Limited(TPLP)	62,545,194 ▼ -0.67
Pak Refinery / Jul 17 Pakistan Refinery Limited(PRL)	38,580,070 ▲ 2.94
WorldCall Telecom / Jul 17 Worldcall Telecom Limited(WTL)	23,499,606 ▼ -0.04
K-Electric Ltd. / Jul 17 K-Electric Limited(KEL)	18,396,866 ▼ -0.24
Lotte Chemical / Jul 17 Lotte Chemical Pakistan Limited(LOTCHEM)	17,830,259 ▼ -1.32
Hascol Petrol / Jul 17 Hascol Petroleum Limited(HASCOL)	14,534,208 ▼ -0.33
B.O.Punjab / Jul 17 The Bank of Punjab(BOP)	12,503,494 ▼ -0.51
TPL REIT Fund I / Jul 17 TPL REIT Fund I(TPLRF1)	11,458,248 ▼ -0.29
PIA Holding Co.Ltd / Jul 17 PIA Holding Company Limited(PIAHCLA)	10,427,355 ▲ 0.51

Novartis

Most Popular